Works about MULTIPLE myeloma treatment

Results: 1802

A new era in myeloma: the advent of chimeric antigen receptor‐T (CAR‐T) cells and bispecific antibodies.

Published in:

Internal Medicine Journal, 2025, v. 55, n. 5, p. 714, doi. 10.1111/imj.16647

By:

Ho, P. Joy;
Li, Eric W.

Publication type:

Article

Bortezomib-based Chemotherapy and Bone-marrow Followed by Renal Transplantation in Multiple Myeloma: A Literature Review.

Published in:

Indian Journal of Transplantation, 2025, v. 19, n. 2, p. 150, doi. 10.4103/ijot.ijot_90_24

By:

Sethi, Jasmine;
Sulaiman, Shabna;
Ramachandran, Raja;
Prakash, Gaurav;
Kanwar, Deepesh;
Nada, Ritambhra;
Rathi, Manish;
Kohli, Harbir Singh

Publication type:

Article

Multiple myeloma. Diagnostic clues in a patient presenting with incapacitating arthralgias.

Published in:

1997

By:

Goodman, R;
Libanati, C

Publication type:

journal article

Lenalidomide, a blockbuster drug for the treatment of multiple myeloma: Semipreparative separation through supercritical fluid chromatography and vibrational circular dichroism spectroscopy.

Published in:

Journal of Separation Science, 2018, v. 41, n. 20, p. 3840, doi. 10.1002/jssc.201800519

By:

Yan, Yilun;
Fan, Jun;
Guo, Dong;
Lin, Yuemei;
Lai, Yecai;
Wang, Tai;
Gao, Hao;
Yao, Xinsheng;
Zhang, Weiguang

Publication type:

Article

Whole-body MRI quantitative biomarkers are associated significantly with treatment response in patients with newly diagnosed symptomatic multiple myeloma following bortezomib induction.

Published in:

2017

By:

Latifoltojar, Arash;
Hall-Craggs, Margaret;
Bainbridge, Alan;
Rabin, Neil;
Popat, Rakesh;
Rismani, Ali;
D'Sa, Shirley;
Dikaios, Nikolaos;
Sokolska, Magdalena;
Antonelli, Michela;
Ourselin, Sebastien;
Yong, Kwee;
Taylor, Stuart;
Halligan, Steve;
Punwani, Shonit;
Taylor, Stuart A

Publication type:

journal article

Efficacy and Safety of Autologous Stem Cell Transplantation in First-Line Treatment and at Relapse in Elderly Patients with Multiple Myeloma.

Published in:

Oncology, 2025, v. 103, n. 5, p. 389, doi. 10.1159/000541541

By:

Klein, Eva-Maria;
Hujic, Sejla;
Miah, Kaya;
Benner, Axel;
Merz, Maximilian;
Bertsch, Uta;
Weinhold, Niels;
Goldschmidt, Hartmut;
Sauer, Sandra

Publication type:

Article

Galectin-8 enhances adhesion of multiple myeloma cells to vascular endothelium and is an adverse prognostic factor.

Published in:

Glycobiology, 2016, v. 26, n. 10, p. 1048, doi. 10.1093/glycob/cww066

By:

Friedel, Myriam;
André, Sabine;
Goldschmidt, Hartmut;
Gabius, Hans-Joachim;
Schwartz-Albiez, Reinhard

Publication type:

Article

Cost-effectiveness of Novel Treatment Sequences for Transplant-Ineligible Patients With Multiple Myeloma.

Published in:

JAMA Network Open, 2021, v. 4, n. 4, p. e213497, doi. 10.1001/jamanetworkopen.2021.3497

By:

Blommestein, Hedwig M.;
Franken, Margreet G.;
van Beurden-Tan, Chrissy H. Y.;
Blijlevens, Nicole M. A.;
Huijgens, Peter C.;
Sonneveld, Pieter;
Uyl-de Groot, Carin A.;
Zweegman, Sonja

Publication type:

Article

A Challenge to Aging Society by microRNA in Extracellular Vesicles: microRNA in Extracellular Vesicles as Promising Biomarkers and Novel Therapeutic Targets in Multiple Myeloma.

Published in:

Journal of Clinical Medicine, 2018, v. 7, n. 3, p. 55, doi. 10.3390/jcm7030055

By:

Yamamoto, Tomofumi;
Kosaka, Nobuyoshi;
Hattori, Yutaka;
Ochiya, Takahiro

Publication type:

Article

Takamatsu, H. Comparison of Minimal Residual Disease Detection by Multiparameter Flow Cytometry, ASO-qPCR, Droplet Digital PCR, and Deep Sequencing in Patients with Multiple Myeloma Who Underwent Autologous Stem Cell Transplantation. J. Clin. Med. 2017, 6, 91

Published in:: 2017
Publication type:: Correction Notice

双靶点 CD38/CD138 CAR-T 细胞的构建及其对多发性骨髓瘤细胞的体外杀伤效果.

Published in:

Chinese Journal of Cancer Biotherapy, 2024, v. 31, n. 12, p. 1186, doi. 10.3872/j.issn.1007-385x.2024.12.003

By:

潘璐;
刘航宇;
王景鸿;
孙大玮;
赵松柏;
鞠吉雨;
宋绚丽

Publication type:

Article

单细胞测序技术在多发性骨髓瘤研究及其精准医疗中的应用.

Published in:

Chinese Journal of Cancer Biotherapy, 2023, v. 30, n. 7, p. 634, doi. 10.3872/j.issn.1007-385x.2023.07.013

By:

黄婷;
王小中

Publication type:

Article

Bilateral Bulky Adrenal Plasmacytomas with Very Good Response to Daratumumab-Based Therapy.

Published in:

Journal of Cancer Research & Practice, 2023, v. 10, n. 2, p. 78, doi. 10.4103/ejcrp.eJCRP-D-22-00027

By:

Fang-Yu Wang;
Han-Kuang Hsieh;
Tso-Fu Wang;
Yi-Feng Wu

Publication type:

Article

Real-world evidence of daratumumab-lenalidomide-dexamethasone in relapsed/refractory multiple myeloma patients: A single-center experience in Taiwan focusing on efficacy.

Published in:

Journal of Cancer Research & Practice, 2023, v. 10, n. 1, p. 19, doi. 10.4103/ejcrp.eJCRP-D-22-00032

By:

Chiu, Ling-Jung;
Kuo, Chin-Yuan;
Ma, Ming-Chun;
Liao, Chun-Kai;
Liu, Hung-Lin;
Wang, Ming-Chung

Publication type:

Article

Anti-Galectin-3 Therapy: A New Chance for Multiple Myeloma and Ovarian Cancer?

Published in:

International Reviews of Immunology, 2014, v. 33, n. 5, p. 417, doi. 10.3109/08830185.2014.911855

By:

Mirandola, Leonardo;
Nguyen, Diane D.;
Rahman, Rakhshanda L.;
Grizzi, Fabio;
Yuefei, Yu;
Figueroa, José A.;
Jenkins, Marjorie R.;
Cobos, Everardo;
Chiriva-Internati, Maurizio

Publication type:

Article

Controversies in smoldering multiple myeloma: finding the optimal approach for treatment initiation.

Published in:

Oncologist, 2025, v. 30, n. 3, p. 1, doi. 10.1093/oncolo/oyae266

By:

Ludwig, Heinz;
Schreder, Martin

Publication type:

Article

Evaluating early intervention in smoldering myeloma clinical trials: a systematic review.

Published in:

Oncologist, 2025, v. 30, n. 2, p. 1, doi. 10.1093/oncolo/oyae219

By:

Kakkilaya, Apoorva;
Trando, Aaron;
Cliff, Edward R Scheffer;
Mian, Hira;
Hadidi, Samer Al;
Aziz, Muhammad;
Goodman, Aaron M;
Jeong, Ah-Reum;
Smith, Wade L;
Kelkar, Amar H;
Russler-Germain, David A;
Mehra, Nikita;
Chakraborty, Rajshekhar;
Gertz, Morie A;
Mohyuddin, Ghulam Rehman

Publication type:

Article

A Prognostic Survival Model Incorporating Patient-Reported Outcomes for Transplant-Ineligible Patients With Multiple Myeloma.

Published in:

Oncologist, 2024, v. 29, n. 6, p. 519, doi. 10.1093/oncolo/oyae041

By:

Mian, Hira;
Seow, Hsien;
Balitsky, Amaris K;
Cheung, Matthew C;
Gayowsky, Anastasia;
Tay, Jason;
Wildes, Tanya M;
McCurdy, Arleigh;
Visram, Alissa;
Sandhu, Irwindeep;
Sutradhar, Rinku

Publication type:

Article

Avelumab, a PD‐L1 Inhibitor, in Combination with Hypofractionated Radiotherapy and the Abscopal Effect in Relapsed Refractory Multiple Myeloma.

Published in:

Oncologist, 2021, v. 26, n. 4, p. 288, doi. 10.1002/onco.13712

By:

Kazandjian, Dickran;
Dew, Alexander;
Hill, Elizabeth;
Ramirez, Elizabeth Gil;
Morrison, Candis;
Mena, Esther;
Lindenberg, Liza;
Yuan, Constance;
Maric, Irina;
Wang, Hao‐Wei;
Calvo, Katherine;
Dulau‐Florea, Alina;
Roswarski, Joseph;
Emanuel, Michael;
Braylan, Raul;
Turkbey, Baris;
Choyke, Peter;
Camphausen, Kevin;
Stetler‐Stevenson, Maryalice;
Steinberg, Seth M.

Publication type:

Article

Individual Trade‐Offs Between Possible Benefits and Risks of Cancer Treatments: Results from a Stated Preference Study with Patients with Multiple Myeloma.

Published in:

Oncologist, 2018, v. 23, n. 1, p. 44, doi. 10.1634/theoncologist.2017-0257

By:

Postmus, Douwe;
Richard, Sarah;
Bere, Nathalie;
van Valkenhoef, Gert;
Galinsky, Jayne;
Low, Eric;
Moulon, Isabelle;
Mavris, Maria;
Salmonsson, Tomas;
Flores, Beatriz;
Hillege, Hans;
Pignatti, Francesco

Publication type:

Article

The European Medicines Agency Review of Carfilzomib for the Treatment of Adult Patients with Multiple Myeloma Who Have Received at Least One Prior Therapy.

Published in:

Oncologist, 2017, v. 22, n. 11, p. 1339, doi. 10.1634/theoncologist.2017-0184

By:

Tzogani, Kyriaki;
Camarero Jiménez, Jorge;
Garcia, Isabel;
Sancho‐López, Arantxa;
Martin, Marc;
Moreau, Alexandre;
Demolis, Pierre;
Salmonson, Tomas;
Bergh, Jonas;
Laane, Edward;
Ludwig, Heinz;
Gisselbrecht, Christian;
Pignatti, Francesco

Publication type:

Article

FDA Approval Summary: Daratumumab for Treatment of Multiple Myeloma After One Prior Therapy.

Published in:

Oncologist, 2017, v. 22, n. 11, p. 1347, doi. 10.1634/theoncologist.2017-0229

By:

Bhatnagar, Vishal;
Gormley, Nicole J.;
Luo, Lola;
Shen, Yuan Li;
Sridhara, Rajeshwari;
Subramaniam, Sriram;
Shen, Guoxiang;
Ma, Lian;
Shord, Stacy;
Goldberg, Kirsten B.;
Farrell, Ann T.;
McKee, Amy E.;
Pazdur, Richard

Publication type:

Article

Solitary plasmacytoma of the femur: A case report.

Published in:

2014

By:

Say, Ferhat;
Gürler, Deniz;
Bülbül, Murat

Publication type:

Case Study

COMPARATIVE COST-EFFECTIVENESS MODELS FOR THE TREATMENT OF MULTIPLE MYELOMA.

Published in:

International Journal of Technology Assessment in Health Care, 2014, v. 30, n. 1, p. 90, doi. 10.1017/S0266462313000615

By:

Cooper, Keith;
Picot, Joanna;
Bryant, Jackie;
Clegg, Andrew

Publication type:

Article

Salvage Autologous Hematopoietic Stem Cell Transplantation Versus Chemoimmunotherapy in Relapsed Multiple Myeloma Patients After First Transplantation; Single Center Data.

Published in:

Journal of Ankara University Faculty of Medicine / Ankara Üniversitesi Tip Fakültesi Mecmuasi, 2023, v. 76, n. 3, p. 200, doi. 10.4274/atfm.galenos.2023.83713

By:

Can, Ferda;
Özkurt, Zübeyde Nur;
Öcal, Ramazan;
Yegin, Zeynep Arzu;
Kaynar, Lale Aydın;
Yağcı, Münci

Publication type:

Article

Proteasome inhibitors bortezomib and carfilzomib used for the treatment of multiple myeloma do not inhibit the serine protease HtrA2/Omi.

Published in:

Toxicology Research, 2016, v. 5, n. 6, p. 1619, doi. 10.1039/c6tx00220j

By:

Csizmadia, Vilmos;
Hales, Paul;
Tsu, Christopher;
Ma, Jingya;
Chen, Jiejin;
Shah, Pooja;
Fleming, Paul;
Senn, Joseph J.;
Kadambi, Vivek J.;
Dick, Larry;
Wolenski, Francis S.

Publication type:

Article

A novel proteasome inhibitor suppresses tumor growth via targeting both 19S proteasome deubiquitinases and 20S proteolytic peptidases.

Published in:

Scientific Reports, 2014, p. 1, doi. 10.1038/srep05240

By:

Ningning Liu;
Chunjiao Liu;
Xiaofen Li;
Siyan Liao;
Wenbin Song;
Changshan Yang;
Chong Zhao;
Hongbiao Huang;
Lixia Guan;
Peiquan Zhang;
Shouting Liu;
Xianliang Hua;
Xin Chen;
Ping Zhou;
Xiaoying Lan;
Songgang Yi;
Shunqing Wang;
Xuejun Wang;
Ping Dou, Q.;
Jinbao Liu

Publication type:

Article

Anti-myeloma Effects of Icariin Are Mediated Through the Attenuation of JAK/STAT3-Dependent Signaling Cascade.

Published in:

Frontiers in Pharmacology, 2018, p. 1, doi. 10.3389/fphar.2018.00531

By:

Young Yun Jung;
Jong Hyun Lee;
Dongwoo Nam;
Narula, Acharan S.;
Namjoshi, Ojas A.;
Blough, Bruce E.;
Jae-Young Um;
Sethi, Gautam;
Kwang Seok Ahn

Publication type:

Article

Long-Term Efficacy of Maintenance Therapy for Multiple Myeloma: A Quantitative Synthesis of 22 Randomized Controlled Trials.

Published in:

Frontiers in Pharmacology, 2018, p. 1, doi. 10.3389/fphar.2018.00430

By:

Li, Jie-Li;
Fan, Guang-Yu;
Liu, Yu-Jie;
Zeng, Zi-Hang;
Huang, Jing-Juan;
Yang, Zong-Ming;
Meng, Xiang-Yu

Publication type:

Article

Withanolide D Exhibits Similar Cytostatic Effect in Drug-Resistant and Drug-Sensitive Multiple Myeloma Cells.

Published in:

Frontiers in Pharmacology, 2017, p. 1, doi. 10.3389/fphar.2017.00610

By:

Issa, Mark E.;
Wijeratne, E. M. K.;
Gunatilaka, A. A. L.;
Cuendet, Muriel

Publication type:

Article

Sanguinarine Induces Apoptosis Pathway in Multiple Myeloma Cell Lines via Inhibition of the JaK2/STAT3 Signaling.

Published in:

Frontiers in Oncology, 2019, p. N.PAG, doi. 10.3389/fonc.2019.00285

By:

Akhtar, Sabah;
Achkar, Iman W.;
Siveen, Kodappully S.;
Kuttikrishnan, Shilpa;
Prabhu, Kirti S.;
Khan, Abdul Q.;
Ahmed, Eiman I.;
Sahir, Fairooz;
Jerobin, Jayakumar;
Raza, Afsheen;
Merhi, Maysaloun;
Elsabah, Hesham M.;
Taha, Ruba;
Omri, Halima El;
Zayed, Hatem;
Dermime, Said;
Steinhoff, Martin;
Uddin, Shahab

Publication type:

Article

MPT0G413, A Novel HDAC6-Selective Inhibitor, and Bortezomib Synergistically Exert Anti-tumor Activity in Multiple Myeloma Cells.

Published in:

Frontiers in Oncology, 2019, p. N.PAG, doi. 10.3389/fonc.2019.00249

By:

Huang, Fang-I;
Wu, Yi-Wen;
Sung, Ting-Yi;
Liou, Jing-Ping;
Lin, Mei-Hsiang;
Pan, Shiow-Lin;
Yang, Chia-Ron

Publication type:

Article

Apixaban for Primary Prevention of Venous Thromboembolism in Patients With Multiple Myeloma Receiving Immunomodulatory Therapy.

Published in:

Frontiers in Oncology, 2019, p. N.PAG, doi. 10.3389/fonc.2019.00045

By:

Cornell, Robert Frank;
Goldhaber, Samuel Z.;
Engelhardt, Brian G.;
Moslehi, Javid;
Jagasia, Madan;
Patton, Daryl;
Harrell, Shelton;
Hall, Robert;
Wyatt, Houston;
Piazza, Greg

Publication type:

Article

Noninvasive Ventilation in Patients With Hematologic Malignancy: A Retrospective Study.

Published in:

Journal of Intensive Care Medicine, 2019, v. 34, n. 3, p. 197, doi. 10.1177/0885066617690725

By:

Liu, Jiajia;
Bell, Conor;
Campbell, Vagia;
DeBacker, Julian;
Tamberg, Erik;
Lee, Christie;
Mehta, Sangeeta

Publication type:

Article

Enterococcus raffinosus infection with atypical hemolytic uremic syndrome in a multiple myeloma patient after autologous stem cell transplant.

Published in:

Hematology Reports, 2017, v. 9, n. 3, p. 107, doi. 10.4081/hr.2017.7094

By:

Mathur, Pankaj;
Hollowoa, Blake;
Lala, Nupur;
Thanendrarajan, Sharmilan;
Matin, Aasiya;
Kothari, Atul;
Schinke, Carolina

Publication type:

Article

Central neurotoxicity of immunomodulatory drugs in multiple myeloma.

Published in:

2015

By:

Patel, Urmeel H.;
Mir, Muhammad A.;
Sivik, Jeffrey K.;
Raheja, Divisha;
Pandey, Manoj K.;
Talamo, Giampaolo

Publication type:

Case Study

Bortezomib-Induced Complete Heart Block and Myocardial Scar: The Potential Role of Cardiac Biomarkers in Monitoring Cardiotoxicity.

Published in:

Case Reports in Cardiology, 2016, p. 1, doi. 10.1155/2016/3456287

By:

Diwadkar, Sachin;
Patel, Aarti A.;
Fradley, Michael G.

Publication type:

Article

Early salivary changes in multiple myeloma patients undergoing autologous HSCT.

Published in:

Oral Diseases, 2018, v. 24, n. 6, p. 972, doi. 10.1111/odi.12866

By:

Van Leeuwen, S. J. M.;
Proctor, G. B.;
Potting, C. M. J.;
Ten Hoopen, S.;
Van Groningen, L. F. J.;
Bronkhorst, E. M.;
Blijlevens, N. M. A.;
Huysmans, M. C. D. N. J. M.

Publication type:

Article

Testing and management for monoclonal gammopathy of uncertain significance and myeloma patients presenting with osteoporosis and fragility fractures.

Published in:

Rheumatology, 2019, v. 58, n. 7, p. 1142, doi. 10.1093/rheumatology/kez127

By:

Nador, Guido;
Ramasamy, Karthik;
Panitsas, Fotios;
Pratt, Guy;
Sadler, Ross;
Javaid, Muhammad Kassim

Publication type:

Article

Safety and Tolerability of Histone Deacetylase (HDAC) Inhibitors in Oncology.

Published in:

2019

By:

Shah, Rashmi R.

Publication type:

journal article

ADRS in Clinical Trials.

Published in:: 2011
Publication type:: Abstract

Pharmacological inhibition of EZH2 combined with DNA-damaging agents interferes with the DNA damage response in MM cells.

Published in:

Molecular Medicine Reports, 2019, v. 19, n. 5, p. 4249

By:

Xu, Li;
Tang, Hailong;
Wang, Kai;
Zheng, Yanhua;
Feng, Juan;
Dong, Hongjuan;
Jin, Yulong;
Cao, Chun;
Chen, Xiequn;
Gao, Guangxun

Publication type:

Article

Decitabine enhances bortezomib treatment in RPMI 8226 multiple myeloma cells.

Published in:

Molecular Medicine Reports, 2016, v. 14, n. 4, p. 3469, doi. 10.3892/mmr.2016.5658

By:

YANG CAO;
GUO-QIANG QIU;
HAO-QING WU;
ZHI-LIN WANG;
YAN LIN;
WEI WU;
XIAO-BAO XIE;
WEI-YING GU

Publication type:

Article

CIP2A regulates proliferation and apoptosis of multiple myeloma cells.

Published in:

Molecular Medicine Reports, 2016, v. 14, n. 3, p. 2705, doi. 10.3892/mmr.2016.5553

By:

ZHUANZHEN ZHENG;
ZHENHUA QIAO;
WENLIANG CHEN;
RONG GONG;
YALIN WANG;
LIANRONG XU;
YANPING MA;
LI ZHANG;
YUJIN LU;
BO JIANG;
GUOXIA LI;
CHUNXIA DONG

Publication type:

Article

Combined therapeutic effects of bortezomib and anacardic acid on multiple myeloma cells via activation of the endoplasmic reticulum stress response.

Published in:

Molecular Medicine Reports, 2016, v. 14, n. 3, p. 2679, doi. 10.3892/mmr.2016.5533

By:

XIAOXIAN DONG;
YUNING LIAO;
NINGNING LIU;
XIANLIANG HUA;
JIANYU CAI;
JINBAO LIU;
HONGBIAO HUANG

Publication type:

Article

Inhibition of multiple myeloma cell proliferation by ginsenoside Rg3 via reduction in the secretion of IGF-1.

Published in:

Molecular Medicine Reports, 2016, v. 14, n. 3, p. 2222, doi. 10.3892/mmr.2016.5475

By:

YAN LI;
TAO YANG;
JING LI;
HONG-LING HAO;
SU-YUN WANG;
JIE YANG;
JIAN-MIN LUO

Publication type:

Article

Paeoniflorin inhibits proliferation and promotes apoptosis of multiple myeloma cells via its effects on microRNA-29b and matrix metalloproteinase-2.

Published in:

Molecular Medicine Reports, 2016, v. 14, n. 3, p. 2143, doi. 10.3892/mmr.2016.5498

By:

SHAOFENG WANG;
WENHUA LIU

Publication type:

Article

Andrographolide inhibits multiple myeloma cells by inhibiting the TLR4/NF-κB signaling pathway.

Published in:

Molecular Medicine Reports, 2016, v. 13, n. 2, p. 1827, doi. 10.3892/mmr.2015.4703

By:

HUI GAO;
JIANRONG WANG

Publication type:

Article

Genistein inhibits the proliferation of human multiple myeloma cells through suppression of nuclear factor-κB and upregulation of microRNA-29b.

Published in:

Molecular Medicine Reports, 2016, v. 13, n. 2, p. 1627, doi. 10.3892/mmr.2015.4740

By:

JIE XIE;
JIANCHAO WANG;
BO ZHU

Publication type:

Article

AMYLOIDOSIS: CHANGING APPROACHES AND OUTCOMES.

Published in:

Methodist DeBakey Cardiovascular Journal, 2012, v. 8, n. 3, p. 2, doi. 10.14797/mdcj-8-3-2

By:

Rice, Lawrence;
Baker, Kelty R.

Publication type:

Article